Search research articles
Contact Us
Filters
Showing results (11-20 of 267) with videos related to
Page
of 27
Sort By:
Best Practice & Research. Clinical Haematology
|
December 4, 2012
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Learning from our failures: the antifungal treatment conundrum
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2002
Antifungal chemoprophylaxis after blood and marrow transplantation
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation
John R Wingard, Helen Leather
F1000Research
|
July 1, 2017
Recent advances in hematopoietic stem cell transplantation
Maxim Norkin, John R Wingard
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 30, 2004
A new era of antifungal therapy
John R Wingard, Helen Leather
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 12, 2012
Armed killers face off against cytomegalovirus
Maxim Norkin, John R Wingard
Mycopathologia
|
February 28, 2009
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients
Baldeep Wirk, John R Wingard
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 16, 2013
Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
Maxim Norkin, John R Wingard
Critical Reviews in Oncology/Hematology
|
February 25, 2009
Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics
John R Wingard, Mohamed Elmongy
Page
of 27
Search research articles
Search
Showing results (11-20 of 267) with videos related to
Sort By:
Page
of 27
Best Practice & Research. Clinical Haematology
|
December 4, 2012
Have novel serum markers supplanted tissue diagnosis for invasive fungal infections in acute leukemia and transplantation?
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Learning from our failures: the antifungal treatment conundrum
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 1, 2002
Antifungal chemoprophylaxis after blood and marrow transplantation
John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2005
Hepatotoxicity associated with antifungal therapy after bone marrow transplantation
John R Wingard, Helen Leather
F1000Research
|
July 1, 2017
Recent advances in hematopoietic stem cell transplantation
Maxim Norkin, John R Wingard
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
January 30, 2004
A new era of antifungal therapy
John R Wingard, Helen Leather
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 12, 2012
Armed killers face off against cytomegalovirus
Maxim Norkin, John R Wingard
Mycopathologia
|
February 28, 2009
Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients
Baldeep Wirk, John R Wingard
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 16, 2013
Diagnostic strategies for invasive fungal infections in patients with hematologic malignancies and hematopoietic stem cell transplant recipients
Maxim Norkin, John R Wingard
Critical Reviews in Oncology/Hematology
|
February 25, 2009
Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics
John R Wingard, Mohamed Elmongy
Page
of 27